The promising drug duo that may improve spinal muscular atrophy (SMA) treatment

In 2016, Spinraza became the first FDA-approved treatment for spinal muscular atrophy. Researchers have found a way the therapeutic effects of Spinraza may be improved. They discovered that pairing Spinraza with a second FDA-approved drug called valproic acid may help optimize Spinraza's efficiency.

from Top Health News -- ScienceDaily https://ift.tt/LC148Yh